ArticleNPJ breast cancer2025

Illuminating the clinicopathological and genomic landscape of HER2-null, ultralow, and low breast cancers: insights into diagnostic discordance between biopsy and surgical excision.

Ming Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.